san 202791 has been researched along with dihydropyridines in 28 studies
| Studies (san 202791) | Trials (san 202791) | Recent Studies (post-2010) (san 202791) | Studies (dihydropyridines) | Trials (dihydropyridines) | Recent Studies (post-2010) (dihydropyridines) |
|---|---|---|---|---|---|
| 31 | 0 | 2 | 5,022 | 529 | 969 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (35.71) | 18.7374 |
| 1990's | 15 (53.57) | 18.2507 |
| 2000's | 3 (10.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lansman, JB; Slesinger, PA | 1 |
| Bolger, GT; O'Neill, SK | 1 |
| Bolger, GT; O'Neill, SK; Triggle, CR | 1 |
| Halushka, PV; Mais, DE; Mayeux, PR | 1 |
| Dannies, PS; Law, GJ; Pachter, JA | 1 |
| de Ree, MM; Gähwiler, BH; Knot, HJ; Rüegg, UT | 1 |
| Brenner, HR; Rotzler, S; Schramek, H | 1 |
| Atwater, I; Boschero, AC; Carroll, PB; De Souza, C | 1 |
| Highsmith, RF; Rapoport, RM; Stauderman, KA | 1 |
| Kamp, TJ; Kongsamut, S; Miller, RJ; Sanguinetti, MC | 1 |
| Rubanyi, GM; Schwartz, A; Vanhoutte, PM | 1 |
| Kokubun, S; Porzig, H; Prod'hom, B; Reuter, H | 2 |
| Brown, AM; Childs, GV; Marchetti, C | 1 |
| Artalejo, CR; Fonteriz, RI; Gandia, L; García, AG; Lopez, MG | 1 |
| Fischmeister, R; Hartzell, HC | 1 |
| Bodewei, R; Hering, S; Kleppisch, T; Timin, EN | 1 |
| Dolphin, AC; Scott, RH | 1 |
| Bacon, KB; Camp, RD; Westwick, J | 1 |
| Baik, YH; French, JF; Rapoport, RM; Schwartz, A | 1 |
| Bolton, TB; Hering, S; Hughes, AD; Timin, EN | 1 |
| Faber, JE; Tateishi, J | 1 |
| Kavalali, ET; Plummer, MR | 1 |
| Bodi, I; He, M; Mikala, G; Schwartz, A | 1 |
| Bodi, I; Hara, M; He, M; Schwartz, A; Varadi, G; Yamaguchi, H | 1 |
| Conklin, MW; Coronado, R; Foell, JD; Haworth, RA; He, J; Kamp, TJ; Wolff, MR | 1 |
| Kan, E; Kelly, JE; Lokuta, AJ; Nishio, M; Sagawa, K; Sagawa, T; Tsai, J; Wasserstrom, JA | 1 |
| Chahine, M; Sculptoreanu, A; Varma, DR | 1 |
28 other study(ies) available for san 202791 and dihydropyridines
| Article | Year |
|---|---|
Inactivating and non-inactivating dihydropyridine-sensitive Ca2+ channels in mouse cerebellar granule cells.
Topics: Animals; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Cerebellum; Cyclic AMP; Dihydropyridines; Electric Stimulation; Male; Membrane Potentials; Mice; Mice, Inbred C57BL | 1991 |
The effects of dihydropyridine calcium channel modulators on pentylenetetrazole convulsions.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amlodipine; Animals; Anticonvulsants; Calcium Channel Agonists; Calcium Channel Blockers; Dihydropyridines; Male; Mice; Nifedipine; Nimodipine; Seizures | 1990 |
Comparative studies with enantiomers of dihydropyridine ligands suggests that there are multiple binding sites associated with the calcium channel.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Brain Chemistry; Calcium Channels; Dihydropyridines; Guinea Pigs; Heart; In Vitro Techniques; Kinetics; Ligands; Male; Mice; Muscle, Smooth; Myocardium; Nitrendipine; Rats; Rats, Inbred Strains; Receptors, Nicotinic; Stereoisomerism | 1990 |
Interactions of dihydropyridine Ca2+ channel agonists with the human platelet thromboxane A2/prostaglandin H2 receptor.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Affinity Labels; Blood Platelets; Calcium Channel Agonists; Calcium Channel Blockers; Dihydropyridines; Fura-2; Humans; In Vitro Techniques; Iodine Radioisotopes; Kinetics; Manganese; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Pyridines; Radioligand Assay; Receptors, Prostaglandin; Receptors, Thromboxane; Stereoisomerism | 1991 |
Ca2+ channel agonists enhance thyrotropin-releasing hormone-induced inositol phosphates and prolactin secretion.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Radioisotopes; Dihydropyridines; Female; In Vitro Techniques; Inositol Phosphates; Nimodipine; Perfusion; Prolactin; Pyridines; Rats; Rats, Inbred Strains; Receptors, Purinergic; Thyrotropin-Releasing Hormone | 1991 |
Modulation of electrical activity and of intracellular calcium oscillations of smooth muscle cells by calcium antagonists, agonists, and vasopressin.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Cells, Cultured; Dihydropyridines; Isradipine; Membrane Potentials; Muscle, Smooth, Vascular; Rats; Vasopressins | 1991 |
Metabolic stabilization of endplate acetylcholine receptors regulated by Ca2+ influx associated with muscle activity.
Topics: Animals; Calcimycin; Calcium; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; Electric Stimulation; Electrophysiology; Half-Life; Male; Motor Endplate; Muscle Denervation; Muscles; Organ Culture Techniques; Potassium; Rats; Rats, Inbred Strains; Receptors, Cholinergic; Ryanodine; Tetrodotoxin | 1991 |
Effects of Ca2+ channel agonist-antagonist enantiomers of dihydropyridine 202791 on insulin release, 45Ca uptake and electrical activity in isolated pancreatic islets.
Topics: Animals; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Dihydropyridines; Female; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Membrane Potentials; Mice; Mice, Inbred Strains; Molecular Conformation; Nifedipine; Rats; Rats, Inbred Strains | 1990 |
Effects of EDCF and endothelin on phosphatidylinositol hydrolysis and contraction in rat aorta.
Topics: Animals; Aorta; Cattle; Cells, Cultured; Culture Media; Dihydropyridines; Endothelins; Endothelium, Vascular; Hydrolysis; In Vitro Techniques; Indomethacin; Inositol Phosphates; Muscle, Smooth, Vascular; Peptides; Phosphatidylinositols; Rats; Sodium Chloride; Trypsin; Trypsin Inhibitors; Vasoconstriction | 1990 |
Calcium channel agonist and antagonist effects of the stereoisomers of the dihydropyridine 202-791.
Topics: Action Potentials; Animals; Calcium; Calcium Channel Blockers; Cell Line; Dihydropyridines; Dose-Response Relationship, Drug; Ion Channels; Isomerism; Membrane Potentials; Mice; Neurons; Pyridines; Rats; Structure-Activity Relationship | 1985 |
The calcium agonists Bay K 8644 and (+)202,791 stimulate the release of endothelial relaxing factor from canine femoral arteries.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Dihydropyridines; Dogs; Endothelium; Femoral Artery; In Vitro Techniques; Ion Channels; Muscle Relaxation; Muscle, Smooth, Vascular; Nifedipine; Pyridines | 1985 |
The voltage-dependent effect of 1,4-dihydropyridine enantiomers on Ca channels in cardiac cells.
Topics: Animals; Calcium Channel Blockers; Dihydropyridines; Electrophysiology; Heart Conduction System; Heart Ventricles; In Vitro Techniques; Ion Channels; Pyridines; Rats; Stereoisomerism; Ventricular Function | 1986 |
Voltage-dependent binding and action of 1,4-dihydropyridine enantiomers in intact cardiac cells.
Topics: Animals; Cells, Cultured; Dihydropyridines; Electric Conductivity; Heart; In Vitro Techniques; Ion Channels; Protein Binding; Pyridines; Rats; Stereoisomerism | 1987 |
Involvement of sodium channels and two types of calcium channels in the regulation of adrenocorticotropin release.
Topics: Adrenocorticotropic Hormone; Animals; Cadmium; Cadmium Chloride; Calcium; Calcium Channel Blockers; Corticotropin-Releasing Hormone; Dihydropyridines; Egtazic Acid; Female; Ion Channels; Male; Nimodipine; Pituitary Gland, Anterior; Pyridines; Rats; Rats, Inbred Strains; Sodium; Tetrodotoxin | 1987 |
Dihydropyridine chirality at the chromaffin cell calcium channel.
Topics: Adrenal Medulla; Animals; Calcium; Catecholamines; Cats; Chromaffin System; Dihydropyridines; Female; Ion Channels; Isradipine; Male; Oxadiazoles; Potassium; Pyridines; Stereoisomerism | 1987 |
Effect of forskolin and acetylcholine on calcium current in single isolated cardiac myocytes.
Topics: Acetylcholine; Animals; Calcium; Calcium Channel Blockers; Colforsin; Cyclic AMP; Dihydropyridines; Heart; Heart Ventricles; In Vitro Techniques; Ion Channels; Isoproterenol; Ranidae; Ventricular Function | 1987 |
Characterization of the calcium channel state transitions induced by the enantiomers of the 1,4-dihydropyridine Sandoz 202 791 in neonatal rat heart cells. A nonmodulated receptor model.
Topics: Animals; Barium; Barium Compounds; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Chlorides; Dihydropyridines; Heart; Ion Channel Gating; Membrane Potentials; Models, Biological; Rats; Rats, Inbred Strains; Stereoisomerism | 1989 |
Interaction between calcium channel ligands and guanine nucleotides in cultured rat sensory and sympathetic neurones.
Topics: Animals; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Dihydropyridines; Gallopamil; Ganglia, Spinal; Ganglia, Sympathetic; Guanine Nucleotides; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Diphosphate; Guanosine Triphosphate; Guanylyl Imidodiphosphate; Ligands; Neurons, Afferent; Nifedipine; Rats; Thionucleotides | 1989 |
Potent and specific inhibition of IL-8-, IL-1 alpha- and IL-1 beta-induced in vitro human lymphocyte migration by calcium channel antagonists.
Topics: Calcium Channel Blockers; Chemotactic Factors; Chemotaxis, Leukocyte; Dihydropyridines; Diltiazem; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Interleukin-1; Interleukin-8; Interleukins; Kinetics; Lymphocytes; Nifedipine; Recombinant Proteins; Verapamil | 1989 |
Dihydropyridine Ca2+ channel agonists and antagonists potentiate ultraviolet light-induced relaxation through cyclic GMP formation in porcine coronary artery.
Topics: Animals; Calcium Channel Agonists; Calcium Channel Blockers; Coronary Vessels; Cyclic GMP; Dihydropyridines; In Vitro Techniques; Muscle Relaxation; Muscle, Smooth, Vascular; Stereoisomerism; Swine; Ultraviolet Rays | 1994 |
Modulation of calcium channels in arterial smooth muscle cells by dihydropyridine enantiomers.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Arteries; Barium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; In Vitro Techniques; Membrane Potentials; Muscle, Smooth, Vascular; Rabbits; Stereoisomerism | 1993 |
Inhibition of arteriole alpha 2- but not alpha 1-adrenoceptor constriction by acidosis and hypoxia in vitro.
Topics: Acidosis; Animals; Arterioles; Calcium Channel Agonists; Calcium Channels; Dihydropyridines; Electrophysiology; Hypoxia; Potassium Chloride; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Vasoconstriction | 1995 |
Selective potentiation of a novel calcium channel in rat hippocampal neurones.
Topics: Animals; Calcium Channels; Dihydropyridines; Electrophysiology; Hippocampus; Ion Channel Gating; Neurons; Rats; Rats, Sprague-Dawley | 1994 |
Motif III S5 of L-type calcium channels is involved in the dihydropyridine binding site. A combined radioligand binding and electrophysiological study.
Topics: Amino Acid Sequence; Animals; Barium; Binding Sites; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cell Line; Dihydropyridines; Female; Humans; Membrane Potentials; Molecular Sequence Data; Mutagenesis, Site-Directed; Oocytes; Point Mutation; Radioligand Assay; Recombinant Fusion Proteins; Xenopus laevis | 1997 |
Molecular studies on the voltage dependence of dihydropyridine action on L-type Ca2+ channels. Critical involvement of tyrosine residues in motif IIIS6 and IVS6.
Topics: Animals; Barium; Calcium Channels; Calcium Channels, L-Type; Dihydropyridines; Female; Isoleucine; Membrane Potentials; Mutagenesis, Site-Directed; Myocardium; Oocytes; Point Mutation; Polymerase Chain Reaction; Rabbits; Stereoisomerism; Xenopus laevis | 1997 |
Reduction in density of transverse tubules and L-type Ca(2+) channels in canine tachycardia-induced heart failure.
Topics: Adrenergic beta-Agonists; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Size; Dihydropyridines; Dogs; Heart Failure; Image Processing, Computer-Assisted; Ion Channel Gating; Isoproterenol; Microscopy, Confocal; Models, Animal; Myocardium; Patch-Clamp Techniques; Tachycardia | 2001 |
Activation of purified cardiac ryanodine receptors by dihydropyridine agonists.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Dihydropyridines; Dogs; Membrane Potentials; Myocardium; Nicotinic Acids; Nifedipine; Oxadiazoles; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Stereoisomerism | 2001 |
Modulation of L-type Ca2+ channels in neonatal rat heart by a novel Ca2+ channel agonist.
Topics: Animals; Animals, Newborn; Azocines; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Dihydropyridines; Myocytes, Cardiac; Patch-Clamp Techniques; Rats | 2003 |